These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 25271250

  • 21. [Metabolic Outcomes of Primary Aldosteronism Patients Receiving Adrenalectomy or Spironolactone Treatments].
    Xu C, Chen T, Mo D, Zhang T, Zhou F, Tian H, Ren Y.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov 20; 54(6):1227-1232. PubMed ID: 38162054
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA.
    Arch Intern Med; 2008 Jan 14; 168(1):80-5. PubMed ID: 18195199
    [Abstract] [Full Text] [Related]

  • 26. Comparison of changes in cardiac structure after treatment in secondary hypertension.
    Yoshitomi Y, Nishikimi T, Abe H, Yoshiwara F, Suzuki T, Ashizawa A, Nagata S, Kuramochi M, Matsuoka H, Omae T.
    Hypertension; 1996 Mar 14; 27(3 Pt 1):319-23. PubMed ID: 8698432
    [Abstract] [Full Text] [Related]

  • 27. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
    Yoneda T, Demura M, Takata H, Kometani M, Karashima S, Yamagishi M, Takeda Y.
    J Clin Endocrinol Metab; 2012 Apr 14; 97(4):1109-13. PubMed ID: 22337911
    [Abstract] [Full Text] [Related]

  • 28. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
    Rossi GP, Cesari M, Letizia C, Seccia TM, Cicala MV, Zinnamosca L, Kuppusamy M, Mareso S, Sciomer S, Iacobone M, Mantero F, Pessina AC.
    J Hypertens; 2014 Jul 14; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
    [Abstract] [Full Text] [Related]

  • 29. EFFICACY OF SPIRONOLACTONE IN ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RESISTANT HYPERTENSION IN COMBINATION WITH RHEUMATOID ARTHRITIS.
    Kondratiuk V, Stakhova A, Hai O, Karmazina O, Karmazin Y.
    Georgian Med News; 2020 Dec 14; (309):51-59. PubMed ID: 33526730
    [Abstract] [Full Text] [Related]

  • 30. Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort.
    Worth PJ, Kunio NR, Siegfried I, Sheppard BC, Gilbert EW.
    Am J Surg; 2015 Oct 14; 210(4):702-9. PubMed ID: 26323999
    [Abstract] [Full Text] [Related]

  • 31. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K, Fujii K, Oniki H, Oka M, Iida M.
    Am J Hypertens; 2006 Jan 14; 19(1):13-8. PubMed ID: 16461184
    [Abstract] [Full Text] [Related]

  • 32. The Relation Between the Degree of Left Ventricular Mass Regression and Serum Potassium Level Change in Patients With Primary Aldosteronism After Adrenalectomy.
    Liao CW, Chen A, Lin YT, Chang YY, Wang SM, Wu VC, Hung CS, Wu KD, Chueh SC, Lin YH, TAIPAI Study Group.
    J Investig Med; 2015 Aug 14; 63(6):816-20. PubMed ID: 26083251
    [Abstract] [Full Text] [Related]

  • 33. Prognostic factors of primary aldosteronism.
    Ou YC, Yang CR, Chang CL, Chang CH, Wu HC, Ho HC, Lin HS, Chang YY.
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb 14; 57(2):118-23. PubMed ID: 8634926
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.
    Fourkiotis V, Vonend O, Diederich S, Fischer E, Lang K, Endres S, Beuschlein F, Willenberg HS, Rump LC, Allolio B, Reincke M, Quinkler M, Mephisto Study Group.
    Eur J Endocrinol; 2013 Jan 14; 168(1):75-81. PubMed ID: 23033260
    [Abstract] [Full Text] [Related]

  • 35. Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.
    Cuspidi C, Tadic M, Sala C, Quarti-Trevano F, Gherbesi E, Mancia G, Grassi G.
    J Hypertens; 2021 Apr 01; 39(4):775-783. PubMed ID: 33044383
    [Abstract] [Full Text] [Related]

  • 36. Effects of antihypertensive therapy on blood pressure and left ventricular hypertrophy in patients with severe hypertension.
    Sumino H, Nakamura T, Kanda T, Sakamaki T, Sato K, Saito Y, Hoshino J, Kurashina T, Ono Z, Takahashi T, Ichikawa S, Kurabayashi M, Nagai R.
    Jpn Heart J; 2000 May 01; 41(3):339-48. PubMed ID: 10987352
    [Abstract] [Full Text] [Related]

  • 37. Targeted Treatment Reverses Increased Left Cardiac Work in Unilateral vs. Bilateral Primary Aldosteronism.
    Kokko E, Viukari M, Koskela JK, Choudhary MK, Matikainen N, Mustonen J, Nevalainen PI, Pörsti I.
    Am J Hypertens; 2024 Oct 14; 37(11):884-892. PubMed ID: 38985455
    [Abstract] [Full Text] [Related]

  • 38. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
    Pan CT, Wu XM, Tsai CH, Chang YY, Chen ZW, Chang CC, Lee BC, Liao CW, Chen YL, Lin LC, Chang YR, Hung CS, Lin YH.
    Front Endocrinol (Lausanne); 2021 Oct 14; 12():646097. PubMed ID: 33953695
    [Abstract] [Full Text] [Related]

  • 39. Will the lessons from primary aldosteronism change the treatment of hypertension and left ventricular hypertrophy?
    Auchus RJ, Drazner MH.
    Hypertension; 2007 Nov 14; 50(5):837-9. PubMed ID: 17909118
    [No Abstract] [Full Text] [Related]

  • 40. Outcomes of adrenalectomy in patients with primary hyperaldosteronism--a single centre experience.
    Hartmann I, Grepl M, Vidlar A, Smakal O, Vaclavik J, Frysak Z, Dolezel M, Student V.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec 14; 158(4):583-90. PubMed ID: 25471827
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.